WHO ICTRP trial
Investigation of patient satisfaction and efficacy of Dovobet Gel in psoriasis…
JPRN-jRCTs031180049 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCTs031180049 |
|---|---|
| Public title | Investigation of patient satisfaction and efficacy of Dovobet Gel in psoriasis patients with poor adherence |
| Scientific title | Investigation of patient satisfaction and efficacy of Dovobet Gel in patients with plaque psoriasis on the body who show poor adherence - INSPADES Study |
| Primary sponsor | Nakagawa Hidemi |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 4 |
| Conditions | Plaque Psoriasis |
| Interventions | An appropriate amount of the investigational product (Dovobet Gel) is applied to plaque psoriasis lesions on the body once daily for 12 weeks. The maximum weekly dose allowed is 90 g. |
| Registration date | Jan 12, 2018 |
| Target size | 50 |
| Registry page | jrct.niph.go.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: